Building a national collaborative network for developing randomized clinical trials on infectious diseases and antimicrobial resistance: A survey in Spanish hospitals
Enfermedades infecciosas y microbiologia clinica (English ed.) · 2026-08 · 44 (7) · 503205
DOI: 10.1016/j.eimce.2026.503205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2026-08. Verfasst von Marcela Salazar-Moscoso und 16 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra (UPF), Barcelona, Spain; Centro de In…. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Communicable Diseases, Drug Resistance, Microbial, Drug Resistance, Bacterial. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Antimicrobial resistance (AMR) is a global health challenge. Clinical trials are essential for evaluating novel and alternative therapeutic strategies. However, conducting randomized clinical trials (RCTs) in infectious diseases faces regulatory, logistical, and financial barriers, as well as challenges in patient recruitment. Collaborative research networks have demonstrated their effectiveness in overcoming these limitations. This study evaluates the capacity of Spanish medical centers to participate in RCTs on infectious diseases and AMR. METHODS: A structured feasibility survey was developed to assess infrastructure, research experience, patient recruitment potential, and willingness to collaborate in Spanish hospitals. Responses were collected using the REDCap platform and analyzed using Microsoft Excel, with results expressed as percentages. RESULTS: Of 90 centers contacted, 65 centers from 17 autonomous communities responded. The majority (78.5%) had dedicated infectious disease departments or units, and 36.9% reported over 1000 annual hospital admissions for infectious diseases. Research experience was strongest in antimicrobial-resistant Gram-negative (84.6%) and Gram-positive bacteria (78.5%). Phase II-IV RCTs were the most conducted trials, predominantly funded by private sources. While 75.4% of centers reported available human resources for research, specialized roles such as project managers (18.5%) and monitors (12.3%) were less common. Notably, 90% of centers expressed willingness to participate in a collaborative network for conducting unfunded RCTs. CONCLUSIONS: The results highlight Spain's strong research infrastructure and expertise in infectious diseases, providing a solid foundation for establishing a national collaborative clinical trials network. However, variations in specialized research personnel and the low frequency of academic trials indicate areas for improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Department, Hospital del Mar, Hospital del Mar Research Institute, Universitat Pompeu Fabra (UPF), Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC),…
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Departamento de Medicina, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain; Cent…
- Infectious Diseases Service, Reina Sofia University Hospital-IMIBIC-UCO, Cordoba, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Departamento de Medicina, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain; Depa…
- Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- Clinical Pharmacology Department, La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, IdiPAZ, Spanish Clinical Research Network (SCReN), Spain.
Zitieren
APA
Salazar-Moscoso, M., Caponcello, M. G., Cosano-Pérez, P., Olivares-Navarro, P., Cogliati-Dezza, F., Barrera, L., Palomo, V., Retamar-Gentil, P., López, J. R. A., Pérez, A. M. B., Conde, A. M., Conde, J. M., Alonso-González, I., Oteo-Iglesias, J., Torre-Cisneros, J., Horcajada, J. P., & Rodríguez-Baño, J. (2026). Building a national collaborative network for developing randomized clinical trials on infectious diseases and antimicrobial resistance: A survey in Spanish hospitals. Enfermedades infecciosas y microbiologia clinica (English ed.), 44(7), 503205. https://doi.org/10.1016/j.eimce.2026.503205
Vancouver
Salazar-Moscoso M, Caponcello MG, Cosano-Pérez P, Olivares-Navarro P, Cogliati-Dezza F, Barrera L, et al. Building a national collaborative network for developing randomized clinical trials on infectious diseases and antimicrobial resistance: A survey in Spanish hospitals. Enfermedades infecciosas y microbiologia clinica (English ed.). 2026;44(7):503205. doi:10.1016/j.eimce.2026.503205
BibTeX
@article{SalazarMoscoso2026,
author = {Salazar-Moscoso, Marcela and Caponcello, Maria Giulia and Cosano-Pérez, Patricia and Olivares-Navarro, Paula and Cogliati-Dezza, Francesco and Barrera, Lydia and Palomo, Virginia and Retamar-Gentil, Pilar and López, Jose Ramón Arribas and Pérez, Alberto Manuel Borobia and Conde, Alberto Moreno and Conde, Jesús Moreno and Alonso-González, Isabela and Oteo-Iglesias, Jesús and Torre-Cisneros, Julián and Horcajada, Juan P and Rodríguez-Baño, Jesús},
title = {Building a national collaborative network for developing randomized clinical trials on infectious diseases and antimicrobial resistance: A survey in Spanish hospitals},
journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
year = {2026},
volume = {44},
number = {7},
pages = {503205},
doi = {10.1016/j.eimce.2026.503205}
}
EUVIMED